|
Polovikov I.P., Zakharova V.L., Sizova Zh.M., Lapidus N.I., Shoikhet D.A., Lenkova N.I.
Glomerulonephritis in patients with previous coronavirus infection. Risks and consequences
|
№3 / 2024
|
|
Grigoryan Z.E., Marchenko Ya.M., Khachatryan M.V.
Features of the course and the prognosis in patients with multiple myeloma depending on the renal involvement
|
№1 / 2024
|
|
Vorotylov A.A., Mikhailova Z.D.
Features of kidney damage in metabolic syndrome
|
№2 / 2023
|
|
L.V. Mikhailova, D.O. Sheleg, R.S. Bogachev
COVID-19 and kidney damage
|
№4 / 2021
|
|
E.V. Voloshinova, K.N. Safarova, E.V. Yakovleva, S.I. Sazhnova
Kidney damage in polycythemia Vera as a problem of interdisciplinary interaction
|
№2 / 2021
|
|
A.A. Ilyushkina, G.V. Baydakova, I.O. Bychkov, N.A. Buruleva, E.Yu. Zakharova
Selective screening for Fabry disease: review of literature data and experience in the Russian Federation
|
№2 / 2020
|
|
V.V. Fomin, A.A. Pulin, O.A. Aksenova, T.Yu. Kustova, S.S. Girina, S.V. Roschupkina, V.A. Kudravtsev, V.A. Varshavskii, E.P. Golitsina, I.V. Damulin, V.V. Panasiuk, N.A. Mukhin
Severe podocyte damage in asymptomatic patient with Fabry disease
|
№1 / 2012
|
|
G.P. Arutiunov, L.G. Oganezova, A.V. Sokolova
Assessment of renal function, involvement of renal glomeruli and tubulo-interstitium in patients with arterial hypertension
|
№6 / 2011
|
|
N.A. Moukhin, L.V. Kozlovskaya, L.Yu. Milovanova, S.V. Tegai, N.B. Gordovskaya, T.M. Ignatova, I.S. Kudlinskii
HCV-associated cryoglobulinemic vasculitis with severe kidney involvement and B-cell lymphoma development. Monoclonal anti-CD-20 antibodies and antiviral therapy as options of prognosis improvement
|
№2 / 2011
|
|
Nephropathy in heroin and cocaine abusers
|
№2 / 2011
|
|
A.A. Demin, V.P. Drobysheva, E.S. Fridman
Kidney involvement and haemostatic disorders in infective endocarditis
|
№4 / 2010
|
|
V.V. Fomin, A.A. Pulin
Nephropathy in Fabry disease: opportunities of dramatic prognosis improvement
|
№1 / 2010
|
Русский
